Call us: 1.405.235.2305
info@i2E.org
  • Events
  • News
  • Resources
  • Library
  • Love’s Cup
i2Ei2Ei2Ei2E
  • About
  • Services
  • Investments
  • Development
  • Portfolio
  • Contact

News

Home Search results for "Mohan Purushothaman"

OKC’s Progentec Diagnostics aims to ‘radically improve’ care of lupus patients

By sarah | News | 0 comment | 4 October, 2019 | 0

By Scott Meacham Lupus is chronic autoimmune condition with devastating effects. The disease is difficult to diagnose. Its course is unpredictable. There is no cure and few FDA-approved medications. Patients who have lupus live with its impact for the rest of their lives. At times, the disease flares up and gets worse; in remission, symptomsRead more

Oklahoma’s bioscience prowess busy making a difference worldwide

By sarah | News | 0 comment | 8 June, 2019 | 0

By Kevan Goff-ParkerCopyright © 2019 The Oklahoman Greater Oklahoma City Chamber Manager of Innovation and Entrepreneurship Evan Fay said he believes some people may be caught off-guard by Oklahoma’s growing bioscience prowess. He made his remarks during the final hours Thursday of the Bio International Conference in Philadelphia as the state’s more than 40 OKBioRead more

OKC-based Progentec Diagnostics refines test to predict future lupus flares

By sarah | News | 0 comment | 6 May, 2019 | 0

By Jim Stafford Copyright © 2019, The Oklahoman Five patients are waiting to see their doctor, each displaying different symptoms. One has a bright rash on her face. Another is suffering from arthritis. Still another has kidney failure, while the fourth patient suffers from heart problems and the fifth is fatigued all the time. TurnsRead more

Progentec Gains Additional Funding for Lupus Detection and Management Platforms

By sarah | News | 0 comment | 8 December, 2018 | 0

By Mary Chapman Lupus News Today Copyright © 2013-2018 All rights reserved. Completion of a second round of funding could help bring closer to market Progentec Diagnostics‘ new tool for predicting lupus flares and a biomarker-based index that monitors underlying disease activity. Funding for Progentec’s biomarker-based diagnostic testing was led by venture capital outfits i2ERead more

Progentec Diagnostics Raises Funds to Support Advances in Lupus Detection and Management

By sarah | News | 0 comment | 2 November, 2018 | 0

– New funding brings lupus-detection tools closer to commercialization  – Acquisition of LupusCorner marks a step forward in developing a first-in-class lupus-management platform OKLAHOMA CITY, Nov. 1, 2018 /PRNewswire/ — Progentec Diagnostics, Inc. (“Progentec”), a leader in the development of technological innovations in the field of diagnostics, today announced the completion of a second roundRead more

Oklahoma Medical Research Foundation a valuable contributor medically — and economically

By sarah | News | 0 comment | 6 September, 2017 | 0

By Scott Meacham Copyright © 2017, The Oklahoma Publishing Co. Over the last year, Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics, has made significant progress on a diagnostic test to identify patients at increased risk for flare in lupus. Lupus is a viciously painful disease that generally surfaces in women inRead more

OMRF’s BioVenture Forum showcases Oklahoma scientific achievements

By sarah | News | 0 comment | 5 April, 2017 | 0

By Jim Stafford Copyright © 2017, The Oklahoma Publishing Co. Seated next to each other on a stage Tuesday morning at the Oklahoma Medical Research Foundation were the alpha and omega of Oklahoma City’s Selexys Pharmaceuticals. Dr. Rodger P. McEver and Russell Rother shared the stage as part of a panel discussion on “Relationship DynamicsRead more

Innovation & Entrpreneurs: Serial entrepreneurs launch own diagnostics-focused company in state

By admin | News | 0 comment | 23 February, 2016 | 0

I get really excited when I see an Oklahoma startup improving the lives of people who have incurable debilitating disease. That’s the story of Progentec Diagnostics, a startup that is focused on developing breakthrough diagnostics. The firm’s initial focus is on developing a diagnostic test to identify patients at increased risk for flare in lupus, an incurable autoimmune disease that afflicts 1.5 million patients in the U.S.

Archives

i2E-300dpi-Trans-Light
  • Events
  • News
  • Resources
  • Library
  • Love’s Cup

Oklahoma City Office

840 Research Parkway, Suite 250
OKC, OK 73104
PHONE 405/235-2305
Click HERE for printable map with directions.

Tulsa Office

618 E. Third Street, Suite 1
Tulsa, OK 74120
PHONE 918/582-5592
Click HERE for printable map with directions.
Copyright 2019 i2E, Inc. | All Rights Reserved
  • About
  • Services
  • Investments
  • Development
    • Love’s Cup
      • Forms
      • High Growth
      • Small Business
      • Timeline
  • Portfolio
  • Contact
i2E